Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label, Single- and Multi-Dose Pharmacokinetic (PK) Study of Oral Diltiazem and Topical Diltiazem Hydrochloride

NCT01816191 is registered in ClinicalTrials.gov with Ventrus Biosciences, Inc as lead sponsor.

NCT NCT01816191
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01816191 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label, Single- and Multi-Dose Pharmacokinetic (PK) Study of Oral Diltiazem and Topical Diltiazem Hydrochloride
Lead sponsor
Ventrus Biosciences, Inc
Phase
Phase 1
Overall status
Unknown status
Start date
February 28, 2013
Completion date
September 30, 2013
Enrollment
12 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adult subjects with anal fissures.